Adverse event following immunization surveillance systems for pregnant women and their infants: a systematic review.

about

A global survey of adverse event following immunization surveillance systems for pregnant women and their infants Adverse event following immunization surveillance systems for pregnant women.

P2860

Q37197142-00FAEC0E-A99C-47B3-BAF1-06018AFA7762 Q46663778-840AA9D4-007F-4C2D-BC9F-FC37AE226275

P2860

Adverse event following immunization surveillance systems for pregnant women and their infants: a systematic review.

Item

http://www.wikidata.org/entity/Q38356351

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Adverse event following immuni ...... infants: a systematic review.

@en

type

Item

label

Adverse event following immuni ...... infants: a systematic review.

@en

prefLabel

Adverse event following immuni ...... infants: a systematic review.

@en

P1476

Adverse event following immuni ...... infants: a systematic review.

@en

P2093

Christine Cassidy

http://www.w3.org/2001/XMLSchema#string

P2860

The Vaccine Safety Datalink: a model for monitoring immunization safety

Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants.

Adverse events following pandemic A (H1N1) 2009 monovalent vaccines in pregnant women--Taiwan, November 2009-August 2010.

Vaccination against H1N1 influenza with Pandemrix(®) during pregnancy and delivery outcome: a Swedish register study.

Pharmacovigilance monitoring of a cohort of pregnant women vaccinated against influenza A(H1N1) variant virus in the Nord-Pas de Calais region of northern France.

Varicella vaccine exposure during pregnancy: data from 10 Years of the pregnancy registry.

Post-licensure safety surveillance for human papillomavirus-16/18-AS04-adjuvanted vaccine: more than 4 years of experience.

Vaccines in pregnancy.

Maternal immunization: US FDA regulatory considerations.

Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System.

P304

361-367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PDS.3754

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Karina A Top

Noni MacDonald

Audrey Steenbeek

P577

2015-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25683692

http://www.w3.org/2001/XMLSchema#string

Adverse event following immunization surveillance systems for pregnant women and their infants: a systematic review.

about

P2860

P2860

Adverse event following immunization surveillance systems for pregnant women and their infants: a systematic review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698